Occludin: a gatekeeper of brain Infection by HIV-1

Fluids Barriers CNS. 2023 Oct 16;20(1):73. doi: 10.1186/s12987-023-00476-7.

Abstract

Compromised structure and function of the blood-brain barrier (BBB) is one of the pathological hallmarks of brain infection by HIV-1. BBB damage during HIV-1 infection has been associated with modified expression of tight junction (TJ) proteins, including occludin. Recent evidence indicated occludin as a redox-sensitive, multifunctional protein that can act as both an NADH oxidase and influence cellular metabolism through AMPK kinase. One of the newly identified functions of occludin is its involvement in regulating HIV-1 infection. Studies suggest that occludin expression levels and the rate of HIV-1 infection share a reverse, bidirectional relationship; however, the mechanisms of this relationship are unclear. In this review, we describe the pathways involved in the regulation of HIV-1 infection by occludin. We propose that occludin may serve as a potential therapeutic target to control HIV-1 infection and to improve the lives of people living with HIV-1.

Keywords: Blood brain barrier; HIV; Occludin; Virus.

Publication types

  • Review

MeSH terms

  • Blood-Brain Barrier / metabolism
  • Brain / metabolism
  • HIV Infections*
  • HIV-1* / metabolism
  • Humans
  • Occludin / metabolism
  • Tight Junction Proteins / metabolism
  • Tight Junctions / metabolism

Substances

  • Occludin
  • Tight Junction Proteins